Avoid Avacta Group (AVCT) by Andrew Woods in The Motley Fool
-
Performance
-6.52%
-
Price at start
46.00p
(bid)
-
Current price
49.00p
(ask)
-
Tip made
01/03/2022
-
Tip Status
Open
Icon Key:
Tip Notes
"...The company is developing some amazing cancer treatments. However, the recent results are not strong enough to encourage me to buy the shares. While I won’t rule out a purchase in the future, I will be standing aside in the near term." - Andrew Woods, The Motley Fool
View Tip Research
NOTE: Stockomendation Ltd is not responsible for any content contained on the page behind the link. Some tip search links need accounts or subscriptions with third parties in order to view the tip.